All products are sourced from licensed pharmacies and provided under medical guidance
It is not intended to replace the advice or attention of health care professionals
doi:10.1007/s40265-020-01353-2 Lau J, Bloch P, Schffer L, et al
Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis
Remember, dont ever self-dose or adjust your medication without your providers advice, and importantly, know your red flags
Although several studies have indicated that the novel antidiabetic drugs, including sodium glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1 RA) and dipeptidyl peptidase 4 inhibitors (DPP4i) provide the cardiovascular benefits in T2DM patients with HFpEF, the elaborated roles and mechanisms are not fully understood